Recent Events & Catalysts
Incyte (INCY) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
Score Changeyesterday
INCY committee score fell 1.4 points
INCY's Committee score moved from 67.05 to 65.62 (-1.43, 1 day(s) apart).
Score Change5d ago
INCY committee score fell 0.6 points
INCY's Committee score moved from 66.24 to 65.62 (-0.62, 1 day(s) apart).
Score Change11d ago
INCY committee score fell 1.4 points
INCY's Committee score moved from 63.83 to 62.40 (-1.43, 1 day(s) apart).
Score Change12d ago
INCY committee score rose 0.3 points
INCY's Committee score moved from 63.52 to 63.83 (+0.31, 1 day(s) apart).
News
Incyte Shares Retreat After Best Day In A Year Despite Opzelura EU Nod
Yahoo · today
RBC Capital Maintains Sector Perform on Incyte, Raises Price Target to $109
Benzinga · today
Incyte Analysts Raise Their Forecasts After Upbeat Q2 Results
Benzinga · today
Guggenheim Maintains Buy on Incyte, Raises Price Target to $150
Benzinga · today
Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis
Yahoo · today
BMO Capital Maintains Market Perform on Incyte, Raises Price Target to $130
Benzinga · today
Top 3 Health Care Stocks That May Implode This Month
Benzinga · today
Barclays Maintains Overweight on Incyte, Raises Price Target to $139
Benzinga · today
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-07-28 · 1d ago · Material
Other events, Financial statements and exhibits
Filed 2026-07-06 · 23d ago
Other events
Filed 2026-06-22 · 37d ago
Submission of matters to a vote of security holders
Filed 2026-06-09 · 50d ago
Other events
Filed 2026-06-08 · 51d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.